계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Rigen Biotech
company
About
Rigen Biotech focuses on the molecular diagnosis of thyroid tumors.
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a variety of solutions for the entire thyroid cancer diagnosis and treatment cycle.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Rigen Biotech has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Apr 14, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | Series Unknown | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Rigen Biotech is funded by 1 investors.
Yinshengtai Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
